If the research project “is led by the Nancy CHRU, and coordinated by Professor Zuily from the vascular medicine department “, indicates in a press release the Nancy hospital, “COVI-DOSE implemented since the start of the pandemic has today reached its target of 1,000 patients included thanks to the active participation of twenty hospitals in France” .
“A unique database”
COVI-DOSE, “the only French essay on the subject has become a world leader on this research theme“, further indicates the CHRU which specifies:”the protocol compares a group of patients benefiting from a usual dose of anticoagulant to another group benefiting from a higher dose and proportionate to the weight of each. The objective is to prove better efficacy of the second treatment, making it possible to reduce the risk of thrombosis in sick people, while ensuring that the treatment does not increase the risk of bleeding.“.
The World Health Organization proposes to use the database “unique made available by the CHRU of Nancy, in partnership with the CHU of Saint-Etienne“. Data that is already being analyzed.
Looking for new funding
Today, communicates the CHRU of Nancy, of “new funding is needed to continue this research “, (…)”to speed up data processing, urgently answer the research question, and promote this trial by the Nancy CHRU internationally” .